Group 1: Performance Overview - The company will disclose its Q1 2026 report on April 24, 2026, and investors are advised to refer to this report for specific performance details [2]. Group 2: Respiratory Device Business Development - The smart connected ventilator has maintained rapid growth since its launch, ranking among the top categories on major e-commerce platforms [2]. - The company launched the C11 smart ventilator in March 2026, featuring a patented multi-level acoustic optimization structure that reduces operational noise to 23 decibels without traditional sound-absorbing materials [2]. - The C11 integrates a cloud-based large language model and intelligent sensing algorithms to automatically compensate for issues like patient repositioning, air leakage, or rapid breathing, while providing users with sleep health insights and personalized recommendations via an app [2]. Group 3: Future Plans - The company aims to continue deepening its focus on respiratory health, steadily advancing product iterations, and enhancing the integration of artificial intelligence with respiratory devices [2]. - Plans include accelerating overseas product certification and channel establishment to boost the international market presence of ventilators [2]. - The company is committed to expanding its global footprint and continuously improving product competitiveness [2].
可孚医疗(301087) - 2026年3月30日投资者关系活动记录表